Skip to content

Based on my analysis of the GO-CAM model and the associated literature, I'll now provide a review of the model "GDP-mannose biosynthetic process from glucose (Mouse)" with ID gomodel:66187e4700003043.

Review of GO-CAM Model: GDP-mannose biosynthetic process from glucose (Mouse)

Model Overview

This GO-CAM model represents the GDP-mannose biosynthetic pathway in mice, starting from glucose rather than mannose. The pathway consists of 5 connected activities performed by different mouse proteins, culminating in the production of GDP-mannose, which is an essential precursor for glycosylation processes.

Model Structure and Flow

The model depicts a linear pathway with the following activities connected by causal relationships:

  1. Hexokinase 1 (HK1, MGI:MGI:96103) - catalyzes the conversion of D-glucopyranose to alpha-D-glucose 6-phosphate in the cytosol
  2. Glucose-6-phosphate isomerase (GPI1, MGI:MGI:95797) - converts alpha-D-glucose 6-phosphate to beta-D-fructofuranose 6-phosphate
  3. Mannose-6-phosphate isomerase (MPI, MGI:MGI:97075) - converts beta-D-fructofuranose 6-phosphate to D-mannose 6-phosphate
  4. Phosphomannomutase 2 (PMM2, MGI:MGI:1859214) - converts D-mannose 6-phosphate to alpha-D-mannose 1-phosphate
  5. GDP-mannose pyrophosphorylase B (GMPPB, MGI:MGI:2660880) - uses alpha-D-mannose 1-phosphate and GTP to generate GDP-alpha-D-mannose and diphosphate

Each activity is properly connected via the "provides input for" (RO:0002413) causal relationship, showing the progression of substrates through the pathway.

Strengths of the Model

  1. Appropriate Gene Products: The model uses the correct mouse genes for each step of the pathway.

  2. Correct Substrates and Products: Each activity has the appropriate inputs and outputs, matching the enzymatic reactions described in the literature.

  3. Subcellular Location: All activities are annotated as occurring in the cytosol (GO:0005829), which is accurate for this metabolic pathway.

  4. Evidence Support: The model includes appropriate evidence codes and literature references for each assertion.

  5. Pathway Context: Each activity is appropriately linked to the GDP-mannose biosynthetic process (GO:0009298).

Issues and Recommendations

  1. Complete Evidence for Locations: While the subcellular locations are properly annotated, some of the evidence references could be strengthened. For example, the evidence for HK1 being in the cytosol uses PMID:12420306, which is appropriate.

  2. Biological Process Consistency: All activities are annotated as being part of GO:0009298 (GDP-mannose biosynthetic process), which is correct. However, it would be beneficial to also include annotations to more specific processes where applicable, such as GO:0061729 (GDP-mannose biosynthetic process from fructose-6-phosphate) for the MPI activity.

  3. Evidence Specificity: Some evidence codes use sequence orthology (ECO:0000266) rather than direct experimental evidence in mice. This is acceptable when mouse-specific data is unavailable, but where possible, mouse-specific evidence would strengthen the model.

Literature Alignment

The model aligns well with the literature regarding the GDP-mannose biosynthetic pathway:

  1. PMID:27053713 provides evidence for PMM2 activity in this pathway, showing how defects in this enzyme cause congenital disorders of glycosylation. This study demonstrated that PMM2 activity is responsible for the conversion of mannose-6-phosphate to mannose-1-phosphate.

  2. PMID:35006422 supports the role of GMPPB in catalyzing the formation of GDP-mannose, and its mutations lead to GMPPB-associated congenital disorders of glycosylation.

  3. PMID:12122025 provides evidence for MPI's role in converting fructose-6-phosphate to mannose-6-phosphate.

Pathway Biology Correctness

The model correctly represents the sequence of enzymatic activities in the GDP-mannose biosynthetic pathway starting from glucose. This pathway is essential for providing GDP-mannose, which serves as a sugar donor for various glycosylation processes including N-glycosylation, O-mannosylation, C-mannosylation, and GPI-anchor formation.

The model correctly shows that glucose is first phosphorylated to glucose-6-phosphate, then isomerized to fructose-6-phosphate, which is then converted to mannose-6-phosphate, followed by conversion to mannose-1-phosphate, and finally to GDP-mannose.

Conclusion

Overall, this GO-CAM model (gomodel:66187e4700003043) is a well-constructed representation of the GDP-mannose biosynthetic pathway from glucose in mice. It includes the correct molecular activities, gene products, inputs/outputs, subcellular locations, and causal connections. The model is supported by appropriate evidence and aligns with the current understanding of this metabolic pathway.

The model meets the GO-CAM best practices and effectively communicates the biological knowledge about this pathway in a clear and accessible manner, making it a valuable resource for understanding the GDP-mannose biosynthetic process.